Clinical Trials
326 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
Radiotherapy Treatments for Neoplasms in the Head and Neck Region
European Institute of Oncology
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
INFLUENCE
Radboud University Medical Center
Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features
Jules Bordet Institute
Evaluation of Quality of Life and Self-assurance and Social Support Earned for Non-cellular Head Cancer
Andrzej Frycz Modrzewski Krakow University
Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications
Sheffield Teaching Hospitals NHS Foundation Trust
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Early Feeding After Oral Cavity Reconstruction
Icahn School of Medicine at Mount Sinai
COACH-ORL
University Hospital, Toulouse
DORIAN
European Institute of Oncology
OPEN
Irish Research Radiation Oncology Group
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
Guy's and St Thomas' NHS Foundation Trust
POSITive
European Institute of Oncology
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
Mahidol University
RADIOCARIES
University of Milan
MK-3475-E90
Wellmarker Bio
HANS
University Medical Center Groningen
HPVNGS
GCS Ramsay Santé pour l'Enseignement et la Recherche
LUSENT
Centre Leon Berard
Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
West China Hospital
Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis
Ottawa Hospital Research Institute
CRISP
Centre hospitalier de l'Université de Montréal (CHUM)
Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence
Regina Elena Cancer Institute
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
Kuwait Cancer Control Center
CLAWED
Sixth Affiliated Hospital, Sun Yat-sen University
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Poitiers University Hospital
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
HiLo
University College, London
EMPOWER
Guy's and St Thomas' NHS Foundation Trust
USmBRT-H
Sunnybrook Health Sciences Centre
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer
Nanfang Hospital, Southern Medical University
V-CHANCE
National Cancer Institute, Naples
Olaparib and Radiotherapy in Head and Neck Cancer
The Netherlands Cancer Institute
DAHANCA PRO
Rigshospitalet, Denmark
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
IMMUNOs-SBRT
Centre Georges Francois Leclerc
Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy
AronPharma Sp. z o. o.
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
Royal Marsden NHS Foundation Trust
MorphineGEL
Instituto Nacional de Cancer, Brazil
HuVeM
East and North Hertfordshire NHS Trust
InGReS
Guy's and St Thomas' NHS Foundation Trust
Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy
Chang Gung Memorial Hospital
Sodium Selenite Supplementation in Patients With Head and Neck Cancer
Chang Gung Memorial Hospital
Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment.
Catholic University of the Sacred Heart
PRO-IMMUNO
University Medical Center Groningen
The GOAL27-6 Study
East and North Hertfordshire NHS Trust
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
Tosk, Inc.
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital